Old Web
English
Sign In
Acemap
>
authorDetail
>
Lori Gabryelski
Lori Gabryelski
Merck & Co.
Clinical trial
Medicine
Clostridioides
Bezlotoxumab
Internal medicine
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies.
2020
Therapeutic Innovation & Regulatory Science
M. Elmer
TransCelerate Biopharma Toolkits Core Team
Cathy Florek
Lori Gabryelski
Alison Greene
Anne Marie L Inglis
Karen L. Johnson
Tanja Keiper
Sean Ludlam
T J Sharpe
Kathyjo Shay
Fabian Somers
Catherine Sutherland
Michele Teufel
Stephen Yates
Show All
Source
Cite
Save
Citations (3)
Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II
2019
Open Forum Infectious Diseases
Mark H. Wilcox
Galia Rahav
Erik R. Dubberke
Lori Gabryelski
Kerrie Davies
Claire Berry
Karen Eves
Misoo C. Ellison
Dalya Guris
Mary Beth Dorr
Show All
Source
Cite
Save
Citations (4)
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II
2019
Clinical Infectious Diseases
Ellie J. C. Goldstein
Diane M. Citron
Dale N. Gerding
Mark H. Wilcox
Lori Gabryelski
Alison Pedley
Zhen Zeng
Mary Beth Dorr
Show All
Source
Cite
Save
Citations (4)
1